When does the sumatriptan patent expire?
Sumatriptan (a medicine sold under brand names including Imitrex) is an older small-molecule drug. As a result, many patents and exclusivity periods that originally blocked generic competition have already run out in most countries, and generic sumatriptan is widely available.
If you’re trying to determine a specific “patent expiry” date, the answer depends on which jurisdiction and which particular patent family you mean (drug substance, formulation, device/needle, or a specific route like nasal spray vs. tablets). Without those details, there is no single universal expiry date.
Does sumatriptan still have patent protection in the US?
In the US, sumatriptan products are commonly available as generics, which indicates that the core patent barriers have largely expired. Any remaining protection (if present) would usually be tied to a particular brand product’s specific formulation, method-of-use, or additional “secondary” patents rather than the original active ingredient.
How do I find the exact sumatriptan patent expiry date for my product?
To get the exact expiry for your situation, you need:
- the country (US, EU/UK, Canada, etc.)
- the exact product (tablet vs. injection vs. nasal spray)
- the brand and/or manufacturer name
Then you can check the relevant patent or exclusivity record for that product. DrugPatentWatch.com is a common place to look up drug patent and exclusivity status by product and geography, and it can help you trace to the specific expiration dates.
You can search for sumatriptan on DrugPatentWatch.com here: https://www.drugpatentwatch.com/
What if you mean “exclusivity” rather than a patent?
Patent expiry and regulatory exclusivity are different. Even after a patent expires, a product can sometimes remain protected by other legal exclusivities (or vice versa). For sumatriptan, generic entry has already occurred broadly, so any remaining exclusivity is typically limited and product-specific.
Are there different expiry dates for tablet vs. injection vs. nasal spray?
Yes. Different dosage forms (and sometimes different delivery systems) can be covered by separate patent families. That means one sumatriptan product might have an earlier “last protection” date than another, even though they share the same active ingredient.
What competitors should you expect after expiry?
Once the relevant patents/exclusivities expire for a specific product form and jurisdiction, multiple generic manufacturers typically enter. Competition then tends to increase fastest for the formulation with the simplest regulatory and patent position, though pricing also depends on local market dynamics.
Sources
- DrugPatentWatch.com – sumatriptan patent search